DC Field | Value | Language |
dc.contributor.author | Bordei, Liuba | - |
dc.date.accessioned | 2020-07-10T13:08:55Z | - |
dc.date.available | 2020-07-10T13:08:55Z | - |
dc.date.issued | 2018 | - |
dc.identifier.citation | BORDEI, Liuba. Gastroesophageal reflux disease association with viral hepatitis B. In: MedEspera: the 7th Internat. Medical Congress for Students and Young Doctors: abstract book. Chișinău: S. n., 2018, p. 88-89. | en_US |
dc.identifier.uri | https://medespera.asr.md/wp-content/uploads/Abastract-Book-2018.pdf | - |
dc.identifier.uri | http://repository.usmf.md/handle/20.500.12710/11237 | - |
dc.description | Nicolae Testemitanu State University of Medicine and Pharmacy of the Republic of Moldova | en_US |
dc.description.abstract | Introduction. Gastro-esophageal reflux disease (GERD) is a common health problem nowadays.
GERD strongly affects the quality of patients’ life and increases the risk for esophageal
adenocarcinoma, affects the public health and leads to a permanent increase of economic burden.
At the same time, all over the world, a huge number of people are infected with viral hepatitis B,
and nearly 400 million are chronic carriers of this virus. Thus, viral hepatitis B is still a serious
danger regarding public health. | en_US |
dc.language.iso | en | en_US |
dc.publisher | MedEspera | en_US |
dc.subject | hepatitis B | en_US |
dc.subject | GERD | en_US |
dc.subject | co-morbidity | en_US |
dc.title | Gastroesophageal reflux disease association with viral hepatitis B | en_US |
dc.type | Article | en_US |
Appears in Collections: | MedEspera 2018
|